Correcetions to 'A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)'
In: Annals of Oncology, Jg. 28 (2017-11-01), S. 2901-2905
Online
unknown
Zugriff:
Titel: |
Correcetions to 'A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)'
|
---|---|
Autor/in / Beteiligte Person: | E.G.E. de Vries ; Zielinski, Christoph C. ; Sobrero, A. ; Dafni, Urania ; Cherny, Nathan I. ; Kerst, J.M. ; Piccart, Martine ; Sullivan, Richard |
Link: | |
Zeitschrift: | Annals of Oncology, Jg. 28 (2017-11-01), S. 2901-2905 |
Veröffentlichung: | Elsevier BV, 2017 |
Medientyp: | unknown |
ISSN: | 0923-7534 (print) |
DOI: | 10.1093/annonc/mdw258 |
Schlagwort: |
|
Sonstiges: |
|